Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial

Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The date has been updated from January 14, 2025, to February 28, 2025.
    Difference
    0.6%
    Check dated 2025-03-03T23:30:03.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:30:23.000Z thumbnail image
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-10T09:37:27.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T05:53:43.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The study on ASP2215 versus salvage chemotherapy for AML with FLT3 mutation has been updated with results posted on January 14, 2025, following the previous submission on August 29, 2024.
    Difference
    3%
    Check dated 2025-01-19T20:02:20.000Z thumbnail image
  9. Check
    69 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant revision.
    Difference
    1.0%
    Check dated 2025-01-12T16:58:42.000Z thumbnail image

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.